Literature DB >> 7540879

Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni).

D G Lalloo1, A J Trevett, D Owens, J Minei, S Naraqi, A Saweri, R A Hutton, R D Theakston, D A Warrell.   

Abstract

The mechanisms of haemostatic failure were studied in 87 patients bitten by the Papuan taipan (Oxyuranus scutellatus canni). Eighty (92%) had evidence of a coagulopathy on laboratory testing; 36 (41.4%) developed spontaneous systemic bleeding, although this was rarely of clinical significance. Coagulation assays in 48 completely defibrinated patients showed marked reductions in factors V and VIII and reductions in factors II, IX, XI, XII and XIIIA. There was a reduction in plasminogen and alpha 2-antiplasmin levels and both total and cross-linked fibrin(ogen) degradation products (FDP) levels were elevated. The mean platelet count was initially decreased and fell further during admission. Similar but less severe changes were seen in patients who were mildly defibrinated. Following treatment with antivenom, fibrinogen levels rose rapidly and coagulability was restored within 6-12 h in 93% of patients. These abnormalities may be primarily attributable to the prothrombin activator present in taipan venom, but it is likely that other uncharacterized venom components contributed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540879     DOI: 10.1097/00001721-199502000-00011

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

1.  Antivenomic characterization of two antivenoms against the venom of the taipan, Oxyuranus scutellatus, from Papua New Guinea and Australia.

Authors:  María Herrera; Owen K Paiva; Ana Helena Pagotto; Alvaro Segura; Solange M T Serrano; Mariángela Vargas; Mauren Villalta; Simon D Jensen; Guillermo León; David J Williams; José María Gutiérrez
Journal:  Am J Trop Med Hyg       Date:  2014-08-25       Impact factor: 2.345

2.  Clotting factor replacement and recovery from snake venom-induced consumptive coagulopathy.

Authors:  Simon G A Brown; Ngaire Caruso; Meredith L Borland; David L McCoubrie; Antonio Celenza; Geoffrey K Isbister
Journal:  Intensive Care Med       Date:  2009-06-23       Impact factor: 17.440

3.  Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.

Authors:  Mariángela Vargas; Alvaro Segura; María Herrera; Mauren Villalta; Ricardo Estrada; Maykel Cerdas; Owen Paiva; Teatulohi Matainaho; Simon D Jensen; Kenneth D Winkel; Guillermo León; José María Gutiérrez; David J Williams
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

4.  Scale reduction of a systems coagulation model with an application to modeling pharmacokinetic-pharmacodynamic data.

Authors:  A Gulati; G K Isbister; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-01-08

5.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

6.  Evaluation of the geographical utility of Eastern Russell's viper (Daboia siamensis) antivenom from Thailand and an assessment of its protective effects against venom-induced nephrotoxicity.

Authors:  Janeyuth Chaisakul; Jaffer Alsolaiss; Mongkon Charoenpitakchai; Kulachet Wiwatwarayos; Nattapon Sookprasert; Robert A Harrison; Narongsak Chaiyabutr; Lawan Chanhome; Choo Hock Tan; Nicholas R Casewell
Journal:  PLoS Negl Trop Dis       Date:  2019-10-23

7.  Analysis of the Composition of Deinagkistrodon acutus Snake Venom Based on Proteomics, and Its Antithrombotic Activity and Toxicity Studies.

Authors:  Jin Huang; Minrui Zhao; Chu Xue; Jiqiang Liang; Fang Huang
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.